- Metabolic Risk Profile and Cancer in Korean Men and Women
-
Seulki Ko, Seok-Jun Yoon, Dongwoo Kim, A-Rim Kim, Eun-Jung Kim, Hye-Young Seo
-
J Prev Med Public Health. 2016;49(3):143-152. Published online May 18, 2016
-
DOI: https://doi.org/10.3961/jpmph.16.021
-
-
12,072
View
-
289
Download
-
38
Crossref
-
Abstract
PDF
- Objectives
Metabolic syndrome is a cluster of risk factors for type 2 diabetes mellitus and cardiovascular disease. Associations between metabolic syndrome and several types of cancer have recently been documented.
Methods We analyzed the sample cohort data from the Korean National Health Insurance Service from 2002, with a follow-up period extending to 2013. The cohort data included 99 565 individuals who participated in the health examination program and whose data were therefore present in the cohort database. The metabolic risk profile of each participant was assessed based on obesity, high serum glucose and total cholesterol levels, and high blood pressure. The occurrence of cancer was identified using Korean National Health Insurance claims data. Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated using Cox proportional hazards models, adjusting for age group, smoking status, alcohol intake, and regular exercise.
Results A total of 5937 cases of cancer occurred during a mean follow-up period of 10.4 years. In men with a high-risk metabolic profile, the risk of colon cancer was elevated (HR, 1.40; 95% CI, 1.14 to 1.71). In women, a high-risk metabolic profile was associated with a significantly increased risk of gallbladder and biliary tract cancer (HR, 2.05; 95% CI, 1.24 to 3.42). Non-significantly increased risks were observed in men for pharynx, larynx, rectum, and kidney cancer, and in women for colon, liver, breast, and ovarian cancer.
Conclusions The findings of this study support the previously suggested association between metabolic syndrome and the risk of several cancers. A high-risk metabolic profile may be an important risk factor for colon cancer in Korean men and gallbladder and biliary tract cancer in Korean women.
-
Summary
-
Citations
Citations to this article as recorded by
- Association of Metabolic Syndrome With Risk of Lung Cancer
Mengmeng Li, Su-Mei Cao, Niki Dimou, Lan Wu, Ji-Bin Li, Jun Yang CHEST.2024; 165(1): 213. CrossRef - Association between insulin resistance, metabolic syndrome and its components and lung cancer: a systematic review and meta-analysis
Jingxuan Liu, Rui Wang, Song Tan, Xiaohu Zhao, Aihua Hou Diabetology & Metabolic Syndrome.2024;[Epub] CrossRef - Association between metabolic syndrome and kidney cancer risk: a prospective cohort study
Lin Wang, Han Du, Chao Sheng, Hongji Dai, Kexin Chen Lipids in Health and Disease.2024;[Epub] CrossRef - Interplay of Cardiometabolic Syndrome and Biliary Tract Cancer: A Comprehensive Analysis with Gender-Specific Insights
Vincenza Di Stasi, Antonella Contaldo, Lucia Birtolo, Endrit Shahini Cancers.2024; 16(19): 3432. CrossRef - Survival benefit of metformin use according to cancer diagnosis in diabetic patients with metabolic syndrome
Ji Soo Park, Soo Jin Moon, Hyung Seok Park, Sang-Hoon Cho Preventive Medicine Reports.2024; 48: 102928. CrossRef - Metabolic syndrome and risk of ovarian cancer: a systematic review and meta-analysis
Ziyu Chen, Zesi Liu, Hongxia Yang, Chaosheng Liu, Fandou Kong Frontiers in Endocrinology.2023;[Epub] CrossRef - Updated epidemiology of gastrointestinal cancers in East Asia
Junjie Huang, Don Eliseo Lucero-Prisno, Lin Zhang, Wanghong Xu, Sunny H. Wong, Siew C. Ng, Martin C. S. Wong Nature Reviews Gastroenterology & Hepatology.2023; 20(5): 271. CrossRef - Association of metabolic syndrome and its components with the risk of kidney cancer: A cohort-based case-control study
Runxue Jiang, Zhi Li, Xia Wang, Haifeng Cai, Shouling Wu, Shuohua Chen, Hailong Hu Technology and Health Care.2023; 31(4): 1235. CrossRef - Association between metabolic syndrome and gastric cancer risk: results from the Health Examinees Study
Dan Huang, Woo-Kyoung Shin, Katherine De la Torre, Hwi-Won Lee, Sukhong Min, Aesun Shin, Jong-Koo Lee, Daehee Kang Gastric Cancer.2023; 26(4): 481. CrossRef - Association Between Metabolic Syndrome and the Risk of Lung Cancer: A
Meta-Analysis
Zhao Zhang, Qinxiang Liu, Congcong Huang, Jun Wu, Yingsheng Wen Hormone and Metabolic Research.2023; 55(12): 846. CrossRef - The association between metabolic risk factors, nonalcoholic fatty liver disease, and the incidence of liver cancer: a nationwide population-based cohort study
Yu-Guang Chen, Chih-Wei Yang, Chi-Hsiang Chung, Ching-Liang Ho, Wei-Liang Chen, Wu-Chien Chien Hepatology International.2022; 16(4): 807. CrossRef - The Importance of Metabolic Syndrome Status for the Risk of Non-Viral Hepatocellular Carcinoma: A Nationwide Population-Based Study
Yuri Cho, Eun Ju Cho, Jeong-Ju Yoo, Young Chang, Goh Eun Chung, In Young Choi, Sang-Hyun Park, Kyungdo Han, Yoon Jun Kim, Jung-Hwan Yoon, Dong Wook Shin, Su Jong Yu Frontiers in Oncology.2022;[Epub] CrossRef - Association of Hypertension and Organ-Specific Cancer: A Meta-Analysis
Morgan Connaughton, Mahsa Dabagh Healthcare.2022; 10(6): 1074. CrossRef - Association Between Metabolic Syndrome and Risk of Renal Cell Cancer: A Meta-Analysis
Wurong Du, Kaibo Guo, Huimin Jin, Leitao Sun, Shanming Ruan, Qiaoling Song Frontiers in Oncology.2022;[Epub] CrossRef - The Association Between Metabolic Syndrome and Colorectal Cancer Risk by Obesity Status in Korean Women: A Nationwide Cohort Study
Seong-geun Moon, Boyoung Park Journal of Preventive Medicine and Public Health.2022; 55(5): 475. CrossRef - The association between hypertension and colorectal cancer: a meta-analysis of observational studies
Kun Xuan, Tianming Zhao, Chenyu Sun, Akash S. Patel, Haixia Liu, Xin Chen, Guangbo Qu, Yehuan Sun European Journal of Cancer Prevention.2021; 30(1): 84. CrossRef - Metabolic syndrome and esophageal cancer risk: a systematic review and meta‑analysis
Jinjia Zhang, Huadong Wu, Rongying Wang Diabetology & Metabolic Syndrome.2021;[Epub] CrossRef - Metabolic syndrome and gastric cancer risk: a systematic review and meta-analysis
Marco Mariani, Michele Sassano, Stefania Boccia European Journal of Cancer Prevention.2021; 30(3): 239. CrossRef - Persistent status of metabolic syndrome and risk of cholangiocarcinoma: A Korean nationwide population-based cohort study
Joo-Hyun Park, Jung Y. Hong, Young S. Park, Gunseog Kang, Kyungdo Han, Joon O. Park European Journal of Cancer.2021; 155: 97. CrossRef - Metabolic syndrome and the risk of colorectal cancer: a systematic review and meta-analysis
Xiaoding Shen, Yong Wang, Rui Zhao, Qianyi Wan, Yutao Wu, Lihao Zhao, Xiaoting Wu International Journal of Colorectal Disease.2021; 36(10): 2215. CrossRef - Metabolic syndrome and its component traits present gender-specific association with liver cancer risk: a prospective cohort study
Bin Xia, Jianjun Peng, De Toni Enrico, Kuiqing Lu, Eddie C. Cheung, Zichong Kuo, Qiangsheng He, Yan Tang, Anran Liu, Die Fan, Changhua Zhang, Yulong He, Yihang Pan, Jinqiu Yuan BMC Cancer.2021;[Epub] CrossRef - Association between Abdominal Obesity and Incident Colorectal Cancer: A Nationwide Cohort Study in Korea
Ga Eun Nam, Se-Jin Baek, Hong Bae Choi, Kyungdo Han, Jung-Myun Kwak, Jin Kim, Seon-Hahn Kim Cancers.2020; 12(6): 1368. CrossRef - Metabolic Syndrome and Risk of Lung Cancer: An Analysis of Korean National Health Insurance Corporation Database
Sooim Sin, Chang-Hoon Lee, Sun Mi Choi, Kyung-Do Han, Jinwoo Lee The Journal of Clinical Endocrinology & Metabolism.2020; 105(11): e4102. CrossRef - Metabolic syndrome and the incidence of lung cancer: a meta-analysis of cohort studies
Li Qiao, Deliang Ma, Hui Lv, Ding Shi, Min Fei, Yu Chen, Fei Xie, Zhuoyan Wang, Ying Wang, Wanhua Liang, Peiying Hu Diabetology & Metabolic Syndrome.2020;[Epub] CrossRef - Metabolic Syndrome and Colorectal Cancer Risk: Results of Propensity Score-Based Analyses in a Community-Based Cohort Study
Jinsun Kim, Eun Young Park, Eunjung Park, Min Kyung Lim, Jin-Kyoung Oh, Byungmi Kim International Journal of Environmental Research and Public Health.2020; 17(22): 8687. CrossRef - The Metabolic Syndrome Is a Risk Factor for Breast Cancer: A Systematic Review and Meta-Analysis
Ping Zhao, Ning Xia, Hong Zhang, Tingting Deng Obesity Facts.2020; 13(4): 384. CrossRef - Metabolic syndrome and liver-related events: a systematic review and meta-analysis
Huina Ren, Junna Wang, Yue Gao, Fuwei Yang, Wenxiang Huang BMC Endocrine Disorders.2019;[Epub] CrossRef - Association between blood pressure and risk of cancer development: a systematic review and meta-analysis of observational studies
Aristeidis Seretis, Sofia Cividini, Georgios Markozannes, Xanthippi Tseretopoulou, David S. Lopez, Evangelia E. Ntzani, Konstantinos K. Tsilidis Scientific Reports.2019;[Epub] CrossRef - Metabolic syndrome and risk of ovarian and fallopian tube cancer in the United States: An analysis of linked SEER–Medicare data
Kara A. Michels, Timothy S. McNeel, Britton Trabert Gynecologic Oncology.2019; 155(2): 294. CrossRef - Association between metabolic syndrome and the incidence of gastric cancer: a meta-analysis of cohort studies
Zhibin Li, Hongfeng Han, Yuan Chang Diabetology & Metabolic Syndrome.2019;[Epub] CrossRef - Association Between Metabolic Syndrome and Breast Cancer Risk: An Updated Meta-Analysis of Follow-Up Studies
Meng Guo, Tingting Liu, Peiting Li, Tianying Wang, Chen Zeng, Meng Yang, Gang Li, Jiang Han, Wei Wu, Ruopeng Zhang Frontiers in Oncology.2019;[Epub] CrossRef - Incidence of Colon Cancer Related to Cigarette Smoking and Alcohol Consumption in Adults with Metabolic Syndrome: Prospective Cohort Study
Ahra Jo, Heeyoung Oh Journal of Korean Academy of Nursing.2019; 49(6): 713. CrossRef - Molecular targets for the therapy of cancer associated with metabolic syndrome (transcription and growth factors)
Natalia V. Yunusova, Irina V. Kondakova, Larisa A. Kolomiets, Sergey G. Afanas'ev, Alena L. Chernyshova, Igor V. Kudryavtsev, Anastasia A. Tsydenova Asia-Pacific Journal of Clinical Oncology.2018; 14(3): 134. CrossRef - Incidence and risk factors of colorectal cancer based on 56 324 health checkups: A 7‐year retrospective cohort study
Toshiko Fujii, Masayuki Ohisa, Toru Sako, Takayuki Harakawa, Kazuaki Sakamune, Shintaro Nagashima, Aya Sugiyama, Yuichiro Matsuura, Junko Tanaka Journal of Gastroenterology and Hepatology.2018; 33(4): 855. CrossRef - The role of metabolic syndrome variant in the malignant tumors progression
Natalia V. Yunusova, Irina V. Kondakova, Larisa A. Kolomiets, Sergey G. Afanas’ev, Anastasia Yu. Kishkina, Liudmila V. Spirina Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2018; 12(5): 807. CrossRef - Specific features of colorectal cancer in patients with metabolic syndrome: a matched case-control analysis of 772 patients
Alban Zarzavadjian Le Bian, Christine Denet, Nicolas Tabchouri, Gianfranco Donatelli, Philippe Wind, Christophe Louvet, Mostefa Bennamoun, Christos Christidis, Thierry Perniceni, David Fuks, Brice Gayet Langenbeck's Archives of Surgery.2018; 403(4): 443. CrossRef - Effect of Work-Related Sedentary Time on Overall Health Profile in Active vs. Inactive Office Workers
Pauline M. Genin, Pascal Dessenne, Julien Finaud, Bruno Pereira, Frederic Dutheil, David Thivel, Martine Duclos Frontiers in Public Health.2018;[Epub] CrossRef - A Case of Endoscopic Submucosal Dissection of Esophageal Adenocarcinoma Arising from Barrett's Esophagus
Joon Sung Kim, Byung-Wook Kim The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2016; 16(3): 169. CrossRef
- The Economic Burden of Cancers Attributable to Metabolic Syndrome in Korea
-
Dongwoo Kim, Seok-Jun Yoon, Young-Hoon Gong, Young Ae Kim, Hye-Young Seo, Jihyun Yoon, A-Rim Kim
-
J Prev Med Public Health. 2015;48(4):180-187. Published online July 20, 2015
-
DOI: https://doi.org/10.3961/jpmph.15.022
-
-
9,825
View
-
115
Download
-
13
Crossref
-
Abstract
PDF
- Objectives
Metabolic syndrome is an important etiologic factor in the development of certain types of cancers. The economic cost of the treatment of cancer has been steadily increasing. We therefore estimated the economic burden of cancers attributable to metabolic syndrome in Korea.
Methods We reviewed metabolic syndrome-related cancers and relative risk and then calculated population attributable fractions. We analyzed insurance claims data for metabolic syndrome-related cancers in 2012 in order to estimate the direct costs associated with these cancers, including hospitalization, outpatient visits, transportation costs, and caregivers’ costs as well as indirect costs such as loss of productivity due to cancer treatment and premature death.
Results In 2012, 18 070 patients in Korea had cancers attributable to metabolic syndrome. The economic burden was USD 199.8 million and the direct and indirect costs were USD 124.5 million and USD 75.3 million, respectively.
Conclusions We estimated the economic burden of cancers attributable to metabolic syndrome in Korea and the efforts are necessary to reduce this burden.
-
Summary
-
Citations
Citations to this article as recorded by
|